6 TECH OUTLOOKDecember - 2019EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comLong healthy life is no accident; it begins with good genes. Many of the most intractable health challenges, from heart disease to cancer, have a genetic component. While, scientists have been trying to manipulate these genes, enhance certain traits, and bring forth a healthy society for decades, they have surpassed expectations over the past three decades due to massive changes in technology. These innovative technologies combined with diminished time and cost barrier of sequencing the whole human genome have not only transformed genomics research, but they also opened the door to new applications for genomics such as clinical genomics. Notably, the marriage between genomics and innovative technologies like big data, artificial intelligence, and machine learning is also making precision medicine a reality. These innovations are enabling the development of highly targeted therapies that offer the potential for improved treatment outcomes, especially for patients battling cancer. Taking note of these telltale signs of a maturing industry, more and more corporate are also getting involved in the space. These corporations are not only from the healthcare industry but also the tech side as well--especially since genomics is equally a technology/data endeavor as it is a biological one.In the wake of such exciting innovations in the healthcare ecosystem, putting together this edition has been an exciting journey for us. In this edition Pharma Tech Outlook, we present to you a list of companies that are transforming the healthcare landscape with innovative technological capabilities around genomics. For example, Breakthrough Genomics, one of the featured companies in this edition of Pharma Tech Outlook, combines AI/ML with genomic medicine to dramatically increase laboratory productivity and help clinicians to zoom in on the disease-causing variant rapidly. This edition also blends thought leadership, from subject-matter experts with real-life stories, on what selected vendors are doing for their clients, including exclusive insights from CIOs and CXOs. We hope this edition will provide you with the right assistance in choosing the best-in-class solution for your requirements.Let us know your thoughts!Genomic Revolution: Reshaping Healthcare Copyright © 2019 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 19 - 2019, Vol 05 - Issue 19 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405Scott JuasyTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >